Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E
Titel:
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E
Auteur:
Chen, Eric X. Kavan, Petr Tehfe, Mustapha Kortmansky, Jeremy S. Sawyer, Michael B. Chiorean, E. Gabriela Lieu, Christopher H. Polite, Blase Wong, Lucas Fakih, Marwan Spencer, Kristen Chaves, Jorge Li, Chenxiang Leconte, Pierre Adelberg, David Kim, Richard